REPOZYTORIUM UNIWERSYTETU
W BIAŁYMSTOKU
UwB

Proszę używać tego identyfikatora do cytowań lub wstaw link do tej pozycji: http://hdl.handle.net/11320/8335
Tytuł: Is the Compulsory Licensing Mechanism Guaranteed by TRIPS the Best Remedy to Improve Access to Biological Therapies Worldwide?
Autorzy: Więckowski, Zbigniew
Słowa kluczowe: compulsory licence
obligatory licensing
patent
biologics
biosimilars
licences
Data wydania: 2019
Data dodania: 3-paź-2019
Wydawca: Publishing House Temida 2
Źródło: Eastern European Journal of Transnational Relations, Vol. 3, No. 1, 2019, p. 39-52
Abstrakt: A compulsory licence is an authorisation under the state administration to use intellectual property rights by third parties, subject to payment of remuneration, regardless of the patent holder's objection. In the Polish legal system, the institution of a compulsory licence is regulated by: the Paris Convention for the Protection of Industrial Property Rights (20 March 1883), the Agreement on Trade-Related Aspects of Intellectual Property Rights (15 April 1994), Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on the granting of compulsory licences for patents relating to the manufacture of pharmaceutical products for export to countries with public health problems and the Industrial Property Law Act (30 June 2000). The basic research thesis of my paper was based on the assumption that a compulsory licence does not meet the objective of providing access to biologics. The regulations governing this institution need to be changed, first of all towards the re-granting of a compulsory licence with the proper meaning of balancing the interests of the public (society) and private (patent holder).
Afiliacja: Cardinal Stephan Wyszynski University in Warsaw, Poland, Law and Administration Faculty
Nota biograficzna: Assistant at Law and Administration Faculty on the Cardinal Stephan Wyszynski University in Warsaw.
E-mail: z.wieckowski@uksw.edu.pl
Sponsorzy: This article was written based on the performance of the scientific research project no. 2017/25/N/HS5/01505 named: Legal model of biosimilars, financed by National Scientific Center.
Opis: I would like to thank dr hab. Marek Świerczyński prof. UKSW for his comments and suggestions, which helped me considerably to improve the article.
URI: http://hdl.handle.net/11320/8335
DOI: 10.15290/eejtr.2019.03.01.03
ISSN: 2544-9214
e-ISSN: 2544-9737
metadata.dc.identifier.orcid: 0000-0001-7753-3743
Typ Dokumentu: Article
Występuje w kolekcji(ach):Eastern European Journal of Transnational Relations, 2019, Vol. 3, No. 1

Pliki w tej pozycji:
Plik Opis RozmiarFormat 
EEJTR (2019) Vol. 3 No. 1 Zbigniew Wieckowski.pdf145,11 kBAdobe PDFOtwórz
Pokaż pełny widok rekordu Zobacz statystyki


Pozycja ta dostępna jest na podstawie licencji Licencja Creative Commons CCL Creative Commons